BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, April 3, 2026
Breaking News: Best of BioWorld Science: Q1
Breaking News: Best of BioWorld Science: Q1
Breaking News: Best of BioWorld Science: Q1
Home
»
Topics
» BioWorld Science, Dermatologic
BioWorld Science, Dermatologic
RSS
Agents for psoriasis and cancers from Roche
June 20, 1997
RXR-selective compounds disclosed by Allergan
June 20, 1997
General Hospital Corp. and Shiseido disclose psoriastatin polypeptides
June 18, 1997
Tazorac approved in the U.S.
June 18, 1997
La Jolla Cancer Res. Found. discloses integrin-binding peptides
June 17, 1997
NYU grants Medco option to license adenosine A2 agonists
June 16, 1997
Cellegy discovers compounds that modulate topical inflammatory and allergic responses
June 16, 1997
Favorable preclinical results with REPEL-CV for cardiovascular surgery
June 13, 1997
Merck & Co. continues to develop 5alpha-reductase inhibitors
June 11, 1997
Inhibitors of 5alpha-reductase prepared by Merck & Co.
June 10, 1997
Previous
1
2
…
391
392
393
394
395
396
397
398
399
…
416
417
Next
RSS